Susquehanna International Group, LLP Titan Pharmaceuticals Inc Call Options Transaction History

Susquehanna International Group, LLP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 16, 2023	SELL	$0.73 - $1.05 $8,468 - $12,180	-11,600 Reduced 51.56%	10,900 $9,000
Q4 2022 Feb 14, 2023	SELL	$0.77 - $22.8 $11,473 - $339,720	-14,900 Reduced 39.84%	22,500 $17,000
Q3 2022 Nov 14, 2022	BUY	$0.53 - $22.6 $13,992 - $596,640	26,400 Added 240.0%	37,400 $40,000
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.94 $988 - $2,444	-2,600 Reduced 19.12%	11,000 $6,000
Q1 2022 May 16, 2022	SELL	$0.89 - $1.26 $54,023 - $76,482	-60,700 Reduced 81.7%	13,600 $13,000
Q4 2021 Feb 14, 2022	BUY	$1.02 - $1.93 $75,786 - $143,399	74,300 New	74,300 $76,000
Q3 2021 Nov 15, 2021	SELL	$1.87 - $2.57 $140,063 - $192,493	-74,900 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$2.24 - $2.9 $284,480 - $368,300	-127,000 Reduced 62.9%	74,900 $195,000
Q1 2021 May 17, 2021	BUY	$2.66 - $4.23 $379,316 - $603,198	142,600 Added 240.47%	201,900 $602,000
Q4 2020 Feb 16, 2021	BUY	$3.0 - $6.0 $177,900 - $355,800	59,300 New	59,300 $195,000

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $49.4M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.